RNA Avidity Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 二月 23, 2026
$7.84
· % 处于52周区间
· 高于低点
· 至高点
$7.6852周低点
$73.0652周高点
市值 (MRQ)
$1.19B
P/E (TTM)
-1.6
EPS (TTM)
$-4.97
收入 (TTM)
$19M
RNA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$7.84
市值 (MRQ)
$1.19B
P/E (TTM)
-1.6
EPS (TTM)
$-4.97
收入 (TTM)
$19M
ROE (TTM)
-44.0%
52周区间
$8–$73
RNA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$19M2018-12-31 → 2025-12-31
EPS$-4.972020-12-31 → 2025-12-31
自由现金流$-664M2020-12-31 → 2025-12-31
净利率-3650.4%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | RNA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.65年均值 ≈-8.5 | ≈-8.5 | · | · | |
| P/S (TTM) | 63.25年均值 ≈253.2 | ≈253.2 | 40.4 | 估值过高 | |
| 市净率 (MRQ) | 0.75年均值 ≈3.2 | ≈3.2 | 2.4 | 估值过高 | |
| 股价/自由现金流 (TTM) | -1.85年均值 ≈-11.2 | ≈-11.2 | · | · | |
| 市现率 (TTM) | -1.85年均值 ≈-11.5 | ≈-11.5 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.75年均值 ≈3.2 | ≈3.2 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | RNA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -3977.3%5年均值 ≈-2624.9% | ≈-2624.9% | -2939.1% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -3977.3%5年均值 ≈-2624.9% | ≈-2624.9% | -1906.4% | 弱 | |
| Pretax Margin (税前利润率) | -3650.4% | · | -3779.8% | 持平 | |
| 净利润率 (TTM) | -3650.4%5年均值 ≈-2395.9% | ≈-2395.9% | -3650.4% | 持平 | |
| ROA (TTM) | -38.9%5年均值 ≈-33.1% | ≈-33.1% | -69.0% | 顶尖 | |
| ROE (TTM) | -44.0%5年均值 ≈-35.6% | ≈-35.6% | -81.2% | 顶尖 | |
| ROIC | -44.2% | · | -60.0% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | RNA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 9.25年均值 ≈11.7 | ≈11.7 | 8.1 | 持平 | |
| Quick Ratio (速动比率) | 2.05年均值 ≈5.3 | ≈5.3 | 4.1 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | RNA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 72.1%5年均值 ≈25.2% | ≈25.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 26.7%5年均值 ≈14.7% | ≈14.7% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 22.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | RNA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.0 | 持平 |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
13.1%
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | $-1.18 | $-1.43 | 17.6% | |
| 2026年3月31日 | 五月 14, 2026 | $-0.97 | $-1.06 | 8.5% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $11M | $10M | $9M | $9M | $7M | $2M | |
| R&D Expense | $559M | $304M | $191M | $150M | $101M | $38M | $15M | |
| SG&A Expense | $206M | $86M | $54M | $38M | $26M | $13M | $5M | |
| Operating Expenses | $765M | $390M | $245M | $188M | $127M | $51M | $20M | |
| Operating Income | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | $-17M | |
| Interest Expense | · | · | · | $0 | $0 | $209.0K | $7M | |
| Other Non-op | $-2M | $-248.0K | $-594.0K | $-57.0K | $-62.0K | $-75.0K | $0 | |
| Pretax Income | $-685M | $-322M | $-212M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | $-25M | |
| EPS (Basic) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| EPS (Diluted) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| Shares (Basic) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| Shares (Diluted) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| EBITDA | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $220M | $185M | $340M | $320M | $321M | $95M | |
| Short-term Investments | · | · | · | · | $85M | $7M | · | |
| Receivables | · | $0 | $1M | $2M | · | · | · | |
| Prepaid Expense | $102M | $41M | $16M | $12M | $6M | · | · | |
| Other Current Assets | $53M | $19M | · | $2M | · | · | · | |
| Current Assets | $1.80B | $1.54B | $611M | $623M | $411M | $332M | $96M | |
| PP&E (Net) | $23M | $13M | $8M | $6M | $5M | $1M | $631.0K | |
| PP&E (Gross) | $35M | $21M | $14M | $9M | $7M | $3M | $2M | |
| Accum. Depreciation | $12M | $8M | $5M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $521.0K | $301.0K | $598.0K | $599.0K | $47.0K | $600.0K | |
| Total Assets | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Accounts Payable | $12M | $8M | $9M | $5M | $3M | $8M | $2M | |
| Current Liabilities | $195M | $98M | $81M | $52M | $30M | $15M | $10M | |
| Capital Leases | $45M | $3M | $6M | $8M | $10M | $938.0K | $393.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $45.0K | |
| Total Liabilities | $269M | $139M | $128M | $61M | $46M | $28M | $28M | |
| Long-term Debt | · | · | · | · | · | · | $5M | |
| Common Stock | $15.0K | $12.0K | $8.0K | $7.0K | $5.0K | $4.0K | $0 | |
| Paid-in Capital | · | · | · | $939M | $566M | $373M | $-43M | |
| Retained Earnings | $-1.58B | $-893M | $-571M | $-359M | $-185M | $-67M | $-22M | |
| AOCI | $3M | $3M | $125.0K | $-3M | $-187.0K | $-5.0K | · | |
| Stockholders' Equity | $1.69B | $1.42B | $501M | $578M | $381M | $306M | $-65M | |
| Liabilities + Equity | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Shares Outstanding | 151,205,000 | 119,893,000 | 79,275,000 | 69,768,000 | 47,754,000 | 37,569,000 | 2,989,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $98M | $51M | $38M | $27M | $17M | $4M | $406.0K | |
| Operating Cash Flow | $-650M | $-301M | $-119M | $-136M | $-95M | $-37M | $2M | |
| CapEx | $13M | $7M | $4M | $3M | $4M | $1M | $235.0K | |
| Investing Cash Flow | $-38M | $-854M | $-130M | $-190M | $-83M | $-8M | $-235.0K | |
| Net Debt Issued | · | · | · | $0 | $0 | $-5M | · | |
| Stock Issued | $837M | $762M | $61M | $345M | $175M | $274M | · | |
| Net Stock Activity | $837M | $762M | $61M | $345M | $20M | · | · | |
| Financing Cash Flow | $851M | $1.19B | $94M | $346M | $176M | $272M | $89M | |
| Net Change in Cash | $163M | $37M | $-155M | $20M | $-1M | $227M | $91M | |
| Free Cash Flow | $-664M | $-308M | $-123M | $-139M | $-99M | $-38M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| Net Margin | -3650.4% | -2957.7% | -2219.9% | -1886.3% | -1265.4% | -653.5% | · | |
| Pretax Margin | -3650.4% | · | · | · | · | · | · | |
| EBITDA Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| ROA | -38.9% | -29.4% | -33.5% | -32.6% | -31.0% | -20.6% | · | |
| ROE | -47.5% | -22.0% | -41.7% | -36.4% | -30.4% | -14.2% | · | |
| ROIC | -44.2% | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 | 22.7 | · | |
| Quick Ratio | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 | 22.5 | · | |
| Interest Coverage | · | · | · | · | · | -211.9 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 19.7 | 5.5 | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.17 | $11.89 | $6.32 | $8.29 | $7.99 | $8.15 | · | |
| Revenue / Share | $0.14 | $0.10 | $0.13 | $0.18 | · | · | · | |
| Cash Flow / Share | $-4.72 | $-2.70 | $-1.63 | $-2.61 | · | · | · | |
| Cash / Share | $2.53 | $1.83 | $2.33 | $4.88 | $6.71 | $8.56 | · | |
| EPS (TTM) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 72.1% | 14.0% | 3.6% | -1.1% | 37.4% | · | · | |
| Revenue CAGR 3Y | 26.7% | 5.3% | 12.1% | · | · | · | · | |
| Revenue CAGR 5Y | 22.5% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $11M | $10M | $9M | $9M | $7M | · | |
| Net Income TTM | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | · | |
| Market Cap | $10.91B | $3.49B | $717M | $1.55B | $1.14B | $959M | · | |
| P/E | -14.5 | -10.1 | -3.1 | -6.6 | -8.3 | -12.4 | · | |
| P/S | 581.5 | 319.9 | 75.0 | 167.8 | 121.7 | 141.3 | · | |
| P/B | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Tangible Book | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Cash Flow | -16.8 | -11.6 | -6.0 | -11.4 | -12.0 | -25.8 | · | |
| P / FCF | -16.4 | -11.3 | -5.8 | -11.1 | -11.5 | -25.1 | · | |
| Earnings Yield | -6.9% | -9.9% | -32.1% | -15.0% | -12.0% | -8.0% | · |
损益表
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $860.0K | $12M | $4M | $2M | $3M | $2M | $2M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| R&D Expense | $167M | $155M | $138M | $99M | $96M | $77M | $64M | $67M | $48M | $43M | $48M | $37M | $40M | $28M | $25M | $23M | |
| SG&A Expense | $89M | $46M | $37M | $34M | $28M | $23M | $21M | $14M | $14M | $12M | $12M | $10M | $9M | $9M | $7M | $6M | |
| Operating Expenses | $255M | $201M | $175M | $133M | $124M | $100M | $85M | $81M | $61M | $55M | $60M | $47M | $48M | $36M | $31M | $29M | |
| Operating Income | $-254M | $-189M | $-171M | $-132M | $-121M | $-98M | $-83M | $-77M | $-59M | $-53M | $-58M | $-45M | $-46M | $-34M | $-29M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $-477.0K | $-380.0K | $-651.0K | $-435.0K | $201.0K | $-232.0K | $-116.0K | $-101.0K | $-13.0K | $-162.0K | $-314.0K | $-12.0K | $-2.0K | $-25.0K | $-11.0K | $-2.0K | |
| Net Income | $-237M | $-174M | $-157M | $-116M | $-102M | $-80M | $-71M | $-69M | $-52M | $-47M | $-52M | $-44M | $-46M | $-34M | $-29M | $-26M | |
| EPS (Basic) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.71 | $-0.66 | $-0.74 | $-0.82 | $-0.92 | $-0.71 | $-0.68 | $-0.70 | |
| EPS (Diluted) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.71 | $-0.66 | $-0.74 | $-0.82 | $-0.92 | $-0.71 | $-0.68 | $-0.70 | |
| Shares (Basic) | · | 137,895,000 | 129,622,000 | 129,232,000 | · | 123,375,000 | 106,928,000 | 87,212,000 | 74,097,000 | 71,390,000 | 70,433,000 | 53,069,000 | 49,927,000 | 48,246,000 | 43,265,000 | 37,583,000 | |
| Shares (Diluted) | · | 137,895,000 | 129,622,000 | 129,232,000 | · | 123,375,000 | 106,928,000 | 87,212,000 | 74,097,000 | 71,390,000 | 70,433,000 | 53,069,000 | 49,927,000 | 48,246,000 | 43,265,000 | 37,583,000 | |
| EBITDA | · | $-189M | $-171M | $-132M | · | $-98M | $-83M | $-77M | $-59M | $-53M | $-58M | $-45M | · | $-34M | $-29M | $-26M |
资产负债表
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $350M | $244M | $254M | $220M | $370M | $576M | $471M | $86M | $154M | $119M | $144M | $125M | $139M | $410M | $276M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $262M | $273M | $258M | $3M | $3M | |
| Receivables | · | · | · | · | · | $0 | $0 | $2M | · | $1M | · | · | · | · | · | · | |
| Prepaid Expense | $102M | $90M | $67M | $55M | $41M | $33M | $30M | $19M | · | $11M | · | · | · | · | · | · | |
| Other Current Assets | $53M | $60M | $43M | · | $19M | · | · | · | · | $6M | · | · | · | · | · | · | |
| Current Assets | $1.80B | $1.97B | $1.25B | $1.43B | $1.54B | $1.62B | $1.33B | $934M | $555M | $595M | $597M | $414M | $404M | $405M | $422M | $287M | |
| PP&E (Net) | $23M | $22M | $21M | $16M | $13M | $9M | $8M | $9M | $8M | $8M | $8M | $6M | $6M | $5M | $3M | $3M | |
| PP&E (Gross) | $35M | $32M | $30M | $24M | $21M | $17M | $15M | $15M | $13M | $12M | $11M | $9M | $9M | $7M | $5M | $4M | |
| Accum. Depreciation | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | $5M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $91M | $91M | $739.0K | $521.0K | $318.0K | $364.0K | $425.0K | $344.0K | $424.0K | $474.0K | $523.0K | $415.0K | $548.0K | $488.0K | $407.0K | |
| Total Assets | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | $573M | $611M | $614M | $431M | $421M | $421M | $426M | $291M | |
| Accounts Payable | $12M | $10M | $4M | $7M | $8M | $8M | $9M | $2M | $6M | $6M | $4M | $26M | $21M | $19M | $12M | $9M | |
| Current Liabilities | $195M | $170M | $135M | $85M | $98M | $91M | $84M | $75M | $49M | $45M | $48M | $43M | $34M | $31M | $22M | $16M | |
| Capital Leases | $45M | $46M | $1M | $2M | $3M | $4M | $5M | $5M | $7M | $6M | $7M | $8M | $9M | $9M | $877.0K | $914.0K | |
| Total Liabilities | $269M | $248M | $176M | $130M | $139M | $137M | $126M | $121M | $56M | $52M | $55M | $54M | $46M | $45M | $31M | $26M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $10.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.58B | $-1.34B | $-1.17B | $-1.01B | $-893M | $-791M | $-710M | $-640M | $-510M | $-458M | $-411M | $-308M | $-264M | $-219M | $-146M | $-117M | |
| AOCI | $3M | $2M | $2M | $3M | $3M | $7M | $-453.0K | $-464.0K | $-2M | $-3M | $-2M | $-3M | $-3M | $-2M | $-1.0K | $0 | |
| Stockholders' Equity | $1.69B | $1.89B | $1.19B | $1.33B | $1.42B | $1.50B | $1.22B | $831M | $517M | $559M | $559M | $377M | $374M | $376M | $395M | $264M | |
| Liabilities + Equity | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | $573M | $611M | $614M | $431M | $421M | $421M | $426M | $291M | |
| Shares Outstanding | 151,205,000 | 146,771,000 | 120,778,000 | 120,512,000 | 119,893,000 | 118,900,000 | 109,266,000 | 95,594,000 | 74,101,000 | 74,070,000 | 70,813,000 | 54,446,000 | 52,081,000 | 49,281,000 | 46,897,000 | 37,665,000 |
现金流
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43M | $19M | $18M | $18M | $14M | $14M | $13M | $10M | $10M | $9M | $9M | $7M | $7M | $6M | $5M | $4M | |
| Operating Cash Flow | $-170M | $-156M | $-200M | $-125M | $-100M | $-66M | $-65M | $-70M | $-37M | $-50M | $-49M | $-32M | $-36M | $-30M | $-21M | $-28M | |
| CapEx | $6M | $712.0K | $3M | $4M | $4M | $2M | $531.0K | $915.0K | $923.0K | $622.0K | $2M | $-107.0K | $1M | $758.0K | $800.0K | $708.0K | |
| Investing Cash Flow | $207M | $-588M | $185M | $157M | $-64M | $-482M | $-275M | $-33M | $-31M | $46M | $-196M | $11M | $-18M | $-175M | $-800.0K | $3M | |
| Stock Issued | $-538.0K | $837M | $0 | $0 | $-500.0K | $324M | $433M | $6M | $0 | $38M | $22M | $39M | $38M | $24M | · | · | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $6M | · | · | $22M | · | · | $24M | · | · | |
| Financing Cash Flow | $-5M | $850M | $4M | $2M | $14M | $342M | $447M | $389M | $40.0K | $39M | $23M | $40M | $39M | $24M | $155M | $413.0K | |
| Net Change in Cash | $32M | $106M | $-10M | $34M | $-150M | $-206M | $107M | $286M | $-68M | $35M | $-222M | $19M | $-14M | $-181M | $134M | $-25M | |
| Free Cash Flow | · | · | · | $-129M | · | · | · | $-71M | · | · | $-51M | · | · | $-30M | · | · |
盈利能力
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | -2080.4% | -2272.6% | -2579.3% | -1810.2% | · | -1919.8% | -1353.7% | -1011.4% | |
| Net Margin | · | -1398.3% | -4089.3% | -7360.0% | · | -3441.7% | -3461.8% | -1943.4% | -1858.0% | -2030.4% | -2346.3% | -1756.6% | · | -1907.2% | -1353.4% | -1010.9% | |
| EBITDA Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | -2080.4% | -2272.6% | -2579.3% | -1810.2% | · | -1919.8% | -1353.7% | -1011.4% | |
| ROA | · | -9.2% | -11.6% | -9.6% | · | -7.3% | -7.2% | -8.8% | -10.4% | -9.1% | -10.1% | -10.2% | · | -9.3% | -7.6% | -8.2% | |
| ROE | · | -10.3% | -13.0% | -10.7% | · | -8.0% | -8.0% | -9.9% | -11.7% | -10.1% | -11.2% | -11.3% | · | -10.3% | -8.2% | -8.9% |
流动性与偿付能力
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.6 | 9.3 | 16.9 | · | 17.8 | 15.8 | 12.5 | 11.4 | 13.1 | 12.4 | 9.7 | · | 13.1 | 18.8 | 17.6 | |
| Quick Ratio | · | 2.1 | 1.8 | 3.0 | · | 4.1 | 6.8 | 6.3 | 1.8 | 3.4 | 2.5 | 9.5 | · | 12.8 | 18.4 | 17.1 |
效率
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 3.5 | 4.5 | · | 3.9 | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $12.85 | $9.87 | $11.03 | · | $12.64 | $11.17 | $8.69 | $6.98 | $7.55 | $7.89 | $6.92 | · | $7.62 | $8.42 | $7.02 | |
| Revenue / Share | · | $0.09 | $0.03 | $0.01 | · | $0.02 | $0.02 | $0.04 | $0.04 | $0.03 | $0.03 | $0.05 | · | · | · | · | |
| Cash Flow / Share | · | · | · | $-0.97 | · | · | · | $-0.81 | · | · | $-0.70 | · | · | · | · | · | |
| Cash / Share | · | $2.39 | $2.02 | $2.11 | · | $3.11 | $5.27 | $4.93 | $1.16 | $2.08 | $1.68 | $2.64 | · | $2.83 | $8.74 | $7.34 | |
| EPS (TTM) | · | $-4.18 | $-3.56 | $-3.00 | · | $-2.89 | $-2.95 | $-2.96 | $-3.00 | $-3.11 | $-3.37 | $-3.29 | $-3.15 | $-2.93 | · | · |
估值 (TTM)
| 指标 | 趋势 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $21M | $11M | $9M | · | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | $10M | $9M | |
| Net Income TTM | · | $-550M | $-456M | $-369M | · | $-280M | $-252M | $-229M | $-202M | $-193M | $-192M | $-162M | $-148M | $-128M | $-96M | $-78M | |
| Market Cap | · | $6.39B | $3.43B | $3.56B | · | $5.46B | $4.46B | $2.44B | $473M | $821M | $1.09B | $889M | · | $910M | $1.16B | $931M | |
| P/E | · | -10.4 | -8.0 | -9.8 | · | -15.9 | -13.8 | -8.6 | -2.1 | -3.6 | -4.6 | -5.0 | -4.6 | -6.3 | · | · | |
| P/S | · | 306.4 | 319.7 | 398.5 | · | 539.8 | 421.1 | 224.4 | 46.6 | 83.8 | 112.5 | 107.0 | 94.7 | 108.1 | 120.1 | 101.2 | |
| P/B | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | 0.9 | 1.5 | 1.9 | 2.4 | · | 2.4 | 2.9 | 3.5 | |
| P / Tangible Book | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | 0.9 | 1.5 | 1.9 | 2.4 | · | 2.4 | 2.9 | 3.5 | |
| P / Cash Flow | · | · | · | -28.5 | · | · | · | -34.7 | · | · | -22.2 | · | · | -30.8 | · | · | |
| Earnings Yield | · | -9.6% | -12.5% | -10.2% | · | -6.3% | -7.2% | -11.6% | -47.0% | -28.0% | -21.9% | -20.2% | -21.7% | -15.9% | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $19M | $11M | $10M | $9M | $9M |
| 营业利润率 % | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% |
| 净收入 | $-685M | $-322M | $-212M | $-174M | $-118M |
| 稀释后每股收益 (EPS) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 |
| 速动比率 | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-664M | $-308M | $-123M | $-139M | $-99M |
机构持有人 (13F) 19 家申报者 · $1.1B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
19
持有价值
$1.1B
新仓位
0
已退出持仓
1
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 0 (0 与上一季度对比) | 1 (-323 与上一季度对比) | 0 (0 与上一季度对比) | 1 (0 与上一季度对比) | -8K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $984520403 | 13649250 | 91.14% | 股份 |
| KRYGER CAPITAL Ltd | $75398932 | 1045320 | 6.98% | 股份 |
| EFG Asset Management (North America) Corp. | $6499913 | 149149 | 0.60% | 股份 |
| AXA Investment Managers S.A. | $4429239 | 101658 | 0.41% | 股份 |
| ANGELO GORDON & CO., L.P. | $3245850 | 45000 | 0.30% | 股份 |
| Toroso Investments, LLC | $2628417 | 36440 | 0.24% | 股份 |
| WOLVERINE TRADING, LLC | $1023120 | 24000 | 0.09% | 买入期权 |
| Orion Portfolio Solutions, LLC | $675595 | 22886 | 0.06% | 股份 |
| CIBC WORLD MARKETS CORP | $552372 | 7658 | 0.05% | 股份 |
| WOLVERINE TRADING, LLC | $456141 | 10700 | 0.04% | 卖出期权 |
| Eisler Capital Management Ltd. | $322088 | 7600 | 0.03% | 买入期权 |
| WOLVERINE TRADING, LLC | $285493 | 6697 | 0.03% | 股份 |
| AlphaQuest LLC | $104589 | 1450 | 0.01% | 股份 |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $19572 | 663 | 0.00% | 股份 |
| Lindbrook Capital, LLC | $16708 | 566 | 0.00% | 股份 |
| FTB Advisors, Inc. | $13915 | 490 | 0.00% | 股份 |
| COMERICA BANK | $11369 | 158 | 0.00% | 股份 |
| Byrne Asset Management LLC | $1372 | 102 | 0.00% | 股份 |
| Hemington Wealth Management | $0 | 7 | 0.00% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RTW Investments, LP, Roderick Wong ×6 申报 | 2025年10月29日 | 3.10% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 21 位内幕人士 · 11 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Sarah Boyce | President and CEO | 2026年2月27日 D | 0 | 0 | 3 | $-1661782 |
| Michael F Maclean | Chief Financial Officer | 2026年2月27日 D | 0 | 0 | 3 | $-471650 |
| Joseph Baroldi | Chief Operating Officer | 2021年2月2日 A | · | 0 | 0 | $0 |
| Charles Calderaro III | Chief Technical Officer | 2026年2月27日 D | 0 | 0 | 1 | $-269201 |
| Kathleen P. Gallagher | Chief Program Officer | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Teresa Mccarthy | Chief Human Resources Officer | 2026年2月27日 D | 0 | 0 | 4 | $-1357138 |
| Michael W. Flanagan | Chief Scientific Officer | 2026年2月27日 D | 0 | 0 | 3 | $-644790 |
| Steven George Hughes | Chief Medical Officer | 2026年2月27日 D | 0 | 0 | 4 | $-631061 |
| Eric Mosbrooker | Chief Commercial Officer | 2026年2月27日 D | 0 | 0 | 1 | $-297784 |
| John B Moriarty | Chief Legal Officer | 2026年2月27日 D | 0 | 0 | 1 | $-171474 |
| Jae B. Kim | Chief Medical Officer | 2021年2月2日 A | · | 0 | 0 | $0 |
| Simona Skerjanec | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Jean Jinsun Kim | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Tamar Thompson | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Noreen Henig | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Troy Edward Wilson | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Edward M. Kaye MD | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| Carsten Boess | 董事 | 2026年2月27日 D | 0 | 0 | 0 | $0 |
| LEVIN ARTHUR A | 董事 | 2026年2月27日 D | 0 | 0 | 1 | $-127367 |
| Alexandria Venture Investments, LLC | 10% 所有者 | 2020年6月16日 C | 502365 | 0 | 0 | $0 |
| Roderick Wong, M.D. | · | 2021年6月16日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 15 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.04% | 49149 SH | 2026年9月11日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.01% | 4391 SH | 2026年10月2日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 82327 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 10724 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.01% | 98494 SH | 2026年9月11日 | 每日 |
| IWM · iShares Trust | 0.00% | 370486 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 2848 SH | 2026年10月2日 | 每日 |
| IWV · iShares Trust | 0.00% | 3307 SH | 2026年9月3日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 188626 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 518416 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 8760 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3882 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 933 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.00% | 3329 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 40842 SH | 2026年9月11日 | 每日 |
RNA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 8 位分析师
买入
中位数目标
$25.00
+218.9%
2 25.0%
强烈买入
5 62.5%
买入
1 12.5%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
4 位分析师 · 2026-09-30平均目标 $25.00 +218.9%
最低$25.00
平均值$25.00
最高$25.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| HURA | · | -1.2 | · | · | · | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-K 于 二月 23, 2026 申报